Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2013 AND VI 31 AND IP 2
Results: 15
1
2
Acknowledging patient heterogeneity in economic evaluation : a systematic literature review.
- Published in:
- 2013
- By:
- Publication type:
- journal article
3
Improving clinical reality in chronic obstructive pulmonary disease economic modelling : development and validation of a micro-simulation approach.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
When does NICE recommend the use of health technologies within a programme of evidence development? : a systematic review of NICE guidance.
- Published in:
- 2013
- By:
- Publication type:
- journal article
5
The authors' reply to wonder and milne: "comparing subsidized access to medicines across payer systems".
- Published in:
- 2013
- By:
- Publication type:
- Letter
6
Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?
- Published in:
- 2013
- By:
- Publication type:
- journal article
7
Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 101, doi. 10.1007/s40273-012-0018-1
- By:
- Publication type:
- Article
8
When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 137, doi. 10.1007/s40273-012-0013-6
- By:
- Publication type:
- Article
9
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 125, doi. 10.1007/s40273-012-0020-7
- By:
- Publication type:
- Article
10
Valuing Benefits to Inform a Clinical Trial in Pharmacy.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 163, doi. 10.1007/s40273-012-0012-7
- By:
- Publication type:
- Article
11
Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 151, doi. 10.1007/s40273-012-0016-3
- By:
- Publication type:
- Article
12
Cost-Effectiveness Acceptability Curves Revisited.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 93, doi. 10.1007/s40273-012-0011-8
- By:
- Publication type:
- Article
13
Acknowledging Patient Heterogeneity in Economic Evaluation.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 111, doi. 10.1007/s40273-012-0015-4
- By:
- Publication type:
- Article
14
Comparing Subsidized Access to Medicines Across Payer Systems.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 173, doi. 10.1007/s40273-012-0010-9
- By:
- Publication type:
- Article
15
The Authors' Reply to Wonder and Milne: 'Comparing Subsidized Access to Medicines Across Payer Systems'.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 2, p. 175, doi. 10.1007/s40273-012-0014-5
- By:
- Publication type:
- Article